Skip to main content

Table 2 Echocardiography results and laboratory data of the study participants

From: Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation

Variables

AF patients (n = 706)

Controls (n = 661)

P

Echocardiography results

   

LAD, mm

40.23 ± 8.40

31.34 ± 4.63

< 0.001

LVDd, mm

46.82 ± 8.44

43.95 ± 5.75

< 0.001

LVSd, mm

33.85 ± 9.17

29.44 ± 6.03

< 0.001

LVEF, %

54.13 ± 12.84

62.20 ± 8.37

< 0.001

Laboratory data

   

TC ≥ 5.2mmol/L, n (%)

178(18.13)

48(7.26)

< 0.001

TG ≥ 1.7mmol/L, n (%)

167(23.65)

96(14.52)

< 0.001

HDL-C < 1mmol/L, n (%)

191(27.05)

166(25.11)

0.414

LDL-C ≥ 3.4mmol/L, n (%)

109(15.44)

18(2.72)

< 0.001

Apo-A1 ≥ 1.6 g/L, n (%)

38(5.38)

48(7.26)

0.153

Apo-B ≥ 1.1 g/L, n (%)

99(14.02)

26(3.93)

< 0.001

ALT, U/L

32.42 ± 25.54

26.80 ± 20.05

< 0.001

AST, U/L

42.49 ± 43.66

29.83 ± 27.88

< 0.001

UN, mmol/L

8.24 ± 5.06

6.46 ± 3.30

< 0.001

Scr, umol/L

125.70 ± 85.70

102.51 ± 70.39

< 0.001

UA, umol/L

412.45 ± 145.89

325.74 ± 110.82

< 0.001

CRP, mg/L

46.59 ± 57.46

41.81 ± 46.65

0.302

WBC, 109/L

9.53 ± 4.55

9.04 ± 4.44

0.563

  1. LAD: left atrium diameter
  2. LVDd: left ventricular end-diastolic diameter
  3. LVSd: left ventricular end-systolic diameter
  4. LVEF: left ventricular ejection fractions
  5. TC: total cholesterol
  6. TG: triglyceride
  7. HDL-C: high-density lipoprotein cholesterol
  8. LDL-C: low-density lipoprotein cholesterol
  9. Apo-A1: apolipoprotein A1
  10. Apo-B: apolipoprotein B
  11. ALT: alanine aminotransferase
  12. AST: aspartate aminotransferase
  13. UN: urea nitrogen
  14. Scr: serum creatinine
  15. UA: uric acid
  16. CRP: C-reactive protein
  17. WBC: white blood cell